Readers respond

Top JAMA editors explain how the editorial-advertising firewall really works

Written byRichard L Glass
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

To the Editor:

The article by Alison McCook, "Journal prints rejected paper—as ad" (April 29, 2005) includes the following statement attributed to Lee Friedman: "Furthermore, editors are not supposed to be able to veto ads, Friedman added." At many major biomedical journals, such as the Journal of the American Medical Association, [and] the New England Journal of Medicine, editors are "blinded" to which ads are going into which issue, to separate editorial from advertising."

This statement is completely inaccurate and the last part of it is backward. As stated by the International Committee of Medical Journal Editors: "Editors must have full and final authority for approving advertisements and enforcing advertising policy." Thus, editors certainly do veto ads. Furthermore, it is advertising sales staff who are blinded to editorial content to be certain that advertising is not sold based on editorial content or placement. Editors must know about "which ads are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform